首页 | 本学科首页   官方微博 | 高级检索  
     

乙肝病毒大蛋白检测在乙型肝炎诊治中的临床意义
引用本文:乐爱平,鞠北华,王文,张文景. 乙肝病毒大蛋白检测在乙型肝炎诊治中的临床意义[J]. 世界华人消化杂志, 2006, 14(16): 1578-1581
作者姓名:乐爱平  鞠北华  王文  张文景
作者单位:南昌大学第一附属医院检验科,江西省,南昌市,330006
摘    要:
目的:探讨乙肝病毒(HBV)大蛋白(LP)在乙型肝炎诊治中的临床意义.方法:对162例HBV感染者YL47A正常对照血清采用酶联免疫吸附试验检测HBV-LP,HBV 前S1抗原,HBV前S2抗原及乙型肝炎血清标志物:FQ-PCR定量检测HBV DNA.结果:在HBV感染组中,HBV-LP与HBV DNA,HBeAg,HBVpreS2,HBVpreS1间相关显署(X2=9.22,11.89,60.35,99.87;均P<0.01),其含量与HBV DNA拷贝数成正相关(rs=0.64, P<0.001),不同HBV DNA拷贝数组别间HBV- LP含量存在差异显著性(X2=135.34,P<0.01); HBeAg,HBV DNA,HBVpreS2,HBVpreS1不同模式间HBV-LP含量及阳性率均存在差异显著性(Z=8.70,5.85,8.44,8.84,均P<0.001); HBeAg阴性感染血清中HBV-LP较HBV DNA, HBVpreS2,HBVpreS1更为敏感(76.8%).HBV 感染组与正常对照组间HBV-LP含量存在差异显著性(P<0.01).结论:HBV-LP是从蛋白水平反映HBV感染者体内病毒复制程度的可靠指标,尤其是 HBeAg阴性患者体内病毒复制及预后判断的良好血清学监测指标.

关 键 词:乙型肝炎病毒  大蛋白  HBV DNA  乙型肝炎病毒前S1抗原  乙型肝炎病毒前S2抗原  酶联免疫吸附试验  荧光定量聚合酶链反应
修稿时间:2006-03-14

Clinical significance of serum hepatitis B virus large surface protein in diagnosis and treatment of patients with hepatitis B
Ai-Ping Le,Bei-Hua Ju,Wen Wang,Wen-Jing Zhang. Clinical significance of serum hepatitis B virus large surface protein in diagnosis and treatment of patients with hepatitis B[J]. World Chinese Journal of Digestology, 2006, 14(16): 1578-1581
Authors:Ai-Ping Le  Bei-Hua Ju  Wen Wang  Wen-Jing Zhang
Abstract:
AIM: To discuss the clinical significance of hepatitis B virus large surface protein (HBV LP) detection in the diagnosis and treatment of patients with hepatitis B. METHODS: Enzyme-linked immunosorbent assay was used to measure the levels of serum HBV-LP, HBV preS1, HBV preS2 and HBV markers, and fluorescence quantitative-polymerase chain reaction (FQ-PCR) was used to detect HBV DNA in 162 patients with hepatitis B as well as 47 normal controls. RESULTS: In serum samples of the patient with HBV infection, the level of HBV-LP had significant correlation with that of HBV DNA, HBeAg, HBVpreS2 and HBVpreS1 antigen (X2 = 9.22, 11.89, 60.35, 99.87; all P < 0.01). The contents of serum HBV-LP was positively correlated with HBV DNA copies (rs = 0.64, P < 0.001). The level of serum HBV-LP was also significantly different between the groups with different HBV DNA copies (P < 0.01). The level and positive rate of serum HBV-LP were significantly different between HBV DNA-positive and negative patients (Z = 5.85, P < 0.001), and they were in the same situation for HBeAg, HBVpreS2 and HBVpreS1 antigen (Z = 8.70, 8.44, 8.84; all P < 0.001). The serum HBV-LP was more sensitive than HBV DNA, HBVpreS2 and HBVpreS1 antigen in HBeAg-negative patients (76.8%). Serum HBV-LP was significantly different between the patients with HBV infection and normal controls (P < 0.01). CONCLUSION: HBV-LP may serve as a reliable marker in the reflection of HBV replication at protein level, and it is valuable to monitor HBV replication and prognosis of the disease, especially in HBeAg-negative HBV infected patients.
Keywords:Hepatitis B virus  Large surface protein  Hepatitis B virus DNA  Hepatitis B virus preS1 antigen  Hepatitis B virus preS2 antigen  Enzyme-linked immunosorbent assay  Fluorescence quantitative polymerase chain reaction
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《世界华人消化杂志》浏览原始摘要信息
点击此处可从《世界华人消化杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号